Drugs / Infanrix-IPV/Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00609492 Background | Jan → Nov 2008 | pneumococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix-IPV/Hib | “booster dose of DTPa-IPV/Hib (Infanrix-IPV/Hib) in preterm born children” NCT00609492 ↗ |
| Known as | DTPa-IPV/Hib | “booster dose of DTPa-IPV/Hib (Infanrix-IPV/Hib) in preterm born children” NCT00609492 ↗ |